"Serum Amyloid A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
| Descriptor ID |
D000685
|
| MeSH Number(s) |
D12.776.049.407.750 D12.776.124.050.725
|
| Concept/Terms |
Serum Amyloid A Protein- Serum Amyloid A Protein
- Amyloid A Protein-Related Serum Component
- Amyloid A Protein Related Serum Component
- Amyloid Protein AA Precursor
- Serum Amyloid Protein A
- Amyloid Serum Protein SAA
- Amyloid-Related Serum Protein (SAA)
- Serum A Related Protein
- Serum Amyloid A
- Amyloid A Precursor
- Amyloid Protein SAA
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid A Protein".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid A Protein".
This graph shows the total number of publications written about "Serum Amyloid A Protein" by people in this website by year, and whether "Serum Amyloid A Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serum Amyloid A Protein" by people in Profiles.
-
Porritt RA, Chase Huizar C, Dick EJ, Kumar S, Escalona R, Gomez AC, Marek-Iannucci S, Noval Rivas M, Patterson J, Forsthuber TG, Arditi M, Gorelik M. Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis. Front Immunol. 2021; 12:630196.
-
Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, Buettner P. Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number. Basic Res Cardiol. 2019 05 08; 114(4):27.
-
Downes KJ, Weiss SL, Gerber JS, Klieger SB, Fitzgerald JC, Balamuth F, Kubis SE, Tolomeo P, Bilker WB, Han X, Nachamkin I, Garrigan C, Han JH, Lautenbach E, Coffin SE. A Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: The Optimizing Antibiotic Strategies in Sepsis (OASIS) Study. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):134-141.
-
Teehan GS, Guo D, Perianayagam MC, Balakrishnan VS, Pereira BJ, Jaber BL. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers. Blood Purif. 2004; 22(4):329-37.
-
Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, Flynn JT. Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice. J Endotoxin Res. 2003; 9(6):341-7.
-
Cabana VG, Gidding SS, Getz GS, Chapman J, Shulman ST. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Pediatr Res. 1997 Nov; 42(5):651-5.
-
Dalakas MC, Cunningham G. Characterization of amyloid deposits in biopsies of 15 with "sporadic" (non-familial or plasma cell dyscrasia amyloid polyneuropathy. Acta Neuropathol. 1986; 69(1-2):66-72.
-
Dalakas MC, Fujihara S, Askanas V, Engel WK, Glenner GG. Nature of amyloid deposits in hypernephroma. Immunocytochemical studies in 2 cases associated with amyloid polyneuropathy. Am J Pathol. 1984 Sep; 116(3):447-54.
-
Dalakas MC, Engel WK. Amyloid in hereditary amyloid polyneuropathy is related to prealbumin. Arch Neurol. 1981 Jul; 38(7):420-2.